Asuragen is to develop and manufacture RNA Control Kits for Affymetrix for use with its in vitro transcription reagent kits for clinical molecular diagnostic applications. Asuragen says the cGMP RNA Control Kits will be configured for use with the GeneChip® System 3000Dx v.2.
The kits will reportedly allow Affymetrix to deliver a complete solution to its molecular diagnostic partners. The GeneChip System 3000Dx v.2 is the only diagnostic microarray platform to have been granted FDA 510(k) clearance and a EU CE mark, Asuragen points out.
As a fully integrated diagnostics company and molecular biology service provider, Asuragen is focused on molecular oncology and genetic diseases. With expertise in the miRNA field, the firm’s current diagnostic portfolio includes Signature® genetic-testing and oncology-testing products as well as controls and standards engineered using its patented Armored RNA® technology.